Resorcinol not identified as a Substance of Very High Concern under REACH
Ingredients: RESORCINOL


The European Commission has shelved its plan to identify resorcinol as an endocrine disrupting SVHC under REACH Regulation.

Resorcinol (EC 203-585-2; CAS 108-46-3) is used to manufacture rubber compounds, resins and coatings, as well as cosmetics mainly as hair dyeing.

In February 2020, France submitted a dossier to the European Chemicals Agency (ECHA) for the identification of resorcinol as a Substance of Very High Concern (SVHC) because of its thyroid disrupting effects in humans and potential neurodevelopmental effects during pregnancy.

In June 2020, a majority of members in the Member State Committee of the Agency (MSC) considered that resorcinol should be identified as an SVHC. However, the MSC did not reach a unanimous agreement. 

After several unsuccessful attempts over 18 months, amid doubts about the scientific evidence behind the Commission’s draft Regulation, the Commission has shelved its plan to identify resorcinol as an endocrine disrupting SVHC under REACH Regulation, after the Commission’s amended proposal for SVHC identification failed to secure EU Member-State approval at a meeting in December 2022.

The European Commission will wait for new CLP hazard classes to enter into force before potentially tabling another proposal for the classification of resorcinol as SVHC.

References:

1. European Commission Implementing Decision on the identification of resorcinol as a substance of very high concern pursuant to Article 57, point (f), of Regulation (EC) No 1907/2006 of the European Parliament and of the Council

other REGULATORY UPDATES

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »
Any REGULATORY QUESTION?

Regulation (EU) 2022/692 – OMNIBUS ACT VI – New and Updated Classification of Cosmetic Ingredients

Ingredients: BENZOPHENONE, TEOPHYLLINE, MELAMINE, AZADIRACHTA EXTRACTS, TRIMETHYLOLPROPANE TRIACRYLATE, PENTETIC ACID, PENTASODIUM PENTETATE

Date of publication: 03/05/2022

Date of application: 01/12/2023

The Commission Delegated Regulation (EU) 2022/692 includes new or updated classification for 12 chemicals that may be used as cosmetic ingredients. Seven out of these 12 are now classified as carcinogenic, mutagenic or toxic to reproduction (CMR) and are banned from cosmetic products marketed in the EU.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »